Has John Thalgott, MD received payments from drug or device companies?

Yes. Drug and device makers reported $320,099 in general payments to John Thalgott, MD across 243 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Thalgott, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Thalgott, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Thalgott, MD

Orthopaedic Surgery of the Spine · Las Vegas, NVNPI 1720071582

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (59.0%), other and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Centinel Spine, LLC at 59.3% of the total. Reporting peaked in 2021 at $76,527 and has fallen 98.7% since, to $988 in 2025. Among orthopaedic surgery of the spine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$320,099in general payments, 2019–2025

Across 243 payments — averaging $1317.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Centinel Spine, LLC$190K
Omnia Medical, LLC$120K
Abbott$5K
Surgalign Spine Technologies, Inc.$3K
Medtronic$1K
Nevro Corp.$560
plus $1K from 18 others

What the payments were for

Royalty or licence$188,78459%
Consulting fees$2,7001%
Food & beverage$8,6153%
Other$120,00037%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Centinel Spine, LLC	68	$189,771
Omnia Medical, LLC	4	$120,000
Abbott	84	$4,619
Surgalign Spine Technologies, Inc.	1	$2,700
Medtronic(2 entities)	27	$1,302
Nevro Corp.	13	$560
Boston Scientific	9	$283
Si-bone, Inc.	7	$188
Saluda Medical Americas, Inc.	4	$109
Johnson & Johnson	4	$76
Zimmer Biomet	4	$75
Pacira Pharmaceuticals Incorporated	3	$63
Solventum Corporation	2	$54
Nalu Medical, Inc.	2	$51
Ulrich Medical USA, Inc.	1	$47
Globus Medical(2 entities)	2	$45
Zimvie Inc.	1	$32
KCI USA, Inc.	1	$31
Providence Medical Technology, Inc.	1	$23
Lemaitre Vascular, Inc.	1	$21
Convatec Inc.	1	$14
International Rehabilitative Sciences, Inc	1	$14
Arbor Pharmaceuticals, Inc.	1	$12
Nabriva Therapeutics, PLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

STALIF M-Ti$107,658
STALIF L$53,347
STALIF M$38,592
MIDLINE II$28,266
MIDLINE II-Ti$27,778
coflex$2,700
PENTA$990
PROCLAIM$646
Proclaim Family of SCS IPGs$572
PRODISC L$500
Penta SCS Leads$372
MYSTIM$265
Proclaim IPG$223
Pacel Bipolar Pacing Catheter$130
SPECTRA WAVEWRITER$118
Omnia$117
Senza II$109
INCEPTIV$104
Octrode SCS Leads$101

How this compares

$320,099 in reported general payments places this provider in the 90th percentile of 30 orthopaedic surgery of the spine providers in Nevada.

See all orthopaedic surgery of the spine providers in Nevada →

Medicare billing

Part B allowed, 2024

$132,406

Medicare patients

218

Services billed

685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	73	$573
Methylprednisolone	42	$244
Levofloxacin	29	$182
Meloxicam	18	$40

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Las Vegas

Kornelis PoelstraLas Vegas$2.2M
George ElkanichLas Vegas$322K
Mark KabinsLas Vegas$118K
Hugh BassewitzLas Vegas$54K
Daniel LeeLas Vegas$52K
Chinedu NwasikeLas Vegas$42K
Kevin DebiparshadLas Vegas$37K
Andrew LeeLas Vegas$31K
Edward AndersonLas Vegas$14K
Daniel LecavalierLas Vegas$8K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →